123 related articles for article (PubMed ID: 36791877)
1. Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination.
Brancaccio G; Coco B; Nardi A; Quaranta MG; Tosti ME; Ferrigno L; Cacciola I; Messina V; Chessa L; Morisco F; Milella M; Barbaro F; Ciancio A; Russo FP; Coppola N; Blanc P; Claar E; Verucchi G; Puoti M; Zignego AL; Chemello L; Madonia S; Fagiuoli S; Marzano A; Ferrari C; Lampertico P; Di Marco V; Craxì A; Santantonio TA; Raimondo G; Brunetto MR; Gaeta GB; Kondili LA;
Int J Infect Dis; 2023 Apr; 129():266-273. PubMed ID: 36791877
[TBL] [Abstract][Full Text] [Related]
2. The present profile of chronic hepatitis B virus infection highlights future challenges: An analysis of the Multicenter Italian MASTER-B cohort.
Brancaccio G; Nardi A; Madonia S; Fasano M; Verucchi G; Massari M; Maimone S; Contini C; Levantesi F; Alfieri A; Gavrila C; Andreone P; Milella M; Gaeta GB
Dig Liver Dis; 2019 Mar; 51(3):438-442. PubMed ID: 30314950
[TBL] [Abstract][Full Text] [Related]
3. A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort.
Kondili LA; Brancaccio G; Tosti ME; Coco B; Quaranta MG; Messina V; Ciancio A; Morisco F; Cossiga V; Claar E; Rosato V; Ciarallo M; Cacciola I; Ponziani FR; Cerrito L; Coppola R; Longobardi F; Biliotti E; Rianda A; Barbaro F; Coppola N; Stanzione M; Barchiesi F; Fagiuoli S; Viganò M; Massari M; Russo FP; Ferrarese A; Laccabue D; Di Marco V; Blanc P; Marrone A; Morsica G; Federico A; Ieluzzi D; Rocco A; Foschi FG; Soria A; Maida I; Chessa L; Milella M; Rosselli Del Turco E; Madonia S; Chemello L; Gentile I; Toniutto P; Bassetti M; Surace L; Baiocchi L; Pellicelli A; De Santis A; Puoti M; Degasperi E; Niro GA; Zignego AL; Craxi A; Raimondo G; Santantonio TA; Brunetto MR; Gaeta GB;
Int J Infect Dis; 2024 May; 146():107115. PubMed ID: 38801968
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study.
Manesis EK; Vourli G; Dalekos G; Vasiliadis T; Manolaki N; Hounta A; Koutsounas S; Vafiadis I; Nikolopoulou G; Giannoulis G; Germanidis G; Papatheodoridis G; Touloumi G
J Hepatol; 2013 Nov; 59(5):949-56. PubMed ID: 23850875
[TBL] [Abstract][Full Text] [Related]
5. Highly dynamic changes of regional HBV epidemiology over two decades.
Ricco G; Coco B; Colombatto P; Oliveri F; Cavallone D; Bleve P; Vianello B; Romagnoli V; Salvati A; Surace L; Bonino F; Brunetto MR
Dig Liver Dis; 2023 Apr; 55(4):519-526. PubMed ID: 36404234
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis Delta Virus Infection in Romania: Prevalence and Risk Factors.
Gheorghe L; Csiki IE; Iacob S; Gheorghe C; Trifan A; Grigorescu M; Motoc A; Suceveanu A; Curescu M; Caruntu F; Sporea I; Brisc C; Rogoveanu I; Cerban R; Tugui L; Alexandrescu A
J Gastrointestin Liver Dis; 2015 Dec; 24(4):413-21. PubMed ID: 26697566
[TBL] [Abstract][Full Text] [Related]
7. Demographics and outcomes of hepatitis B and D: A 10-year retrospective analysis in a Swiss tertiary referral center.
Vieira Barbosa J; Sahli R; Aubert V; Chaouch A; Moradpour D; Fraga M
PLoS One; 2021; 16(4):e0250347. PubMed ID: 33905426
[TBL] [Abstract][Full Text] [Related]
8. Association of Coexistent Hepatitis B Surface Antigen and Antibody With Severe Liver Fibrosis and Cirrhosis in Treatment-Naive Patients With Chronic Hepatitis B.
Wang J; Ding W; Liu J; Liu Y; Yan X; Xia J; Wu W; Jia B; Chen Y; Gao D; Hong S; Wang X; Wang L; Tong X; Yin S; Zhang Z; Li J; Huang R; Wu C
JAMA Netw Open; 2022 Jun; 5(6):e2216485. PubMed ID: 35696167
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea.
Kim HS; Kim SJ; Park HW; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
J Med Virol; 2011 Jul; 83(7):1172-7. PubMed ID: 21541950
[TBL] [Abstract][Full Text] [Related]
10. The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis.
Stockdale AJ; Kreuels B; Henrion MYR; Giorgi E; Kyomuhangi I; de Martel C; Hutin Y; Geretti AM
J Hepatol; 2020 Sep; 73(3):523-532. PubMed ID: 32335166
[TBL] [Abstract][Full Text] [Related]
11. Influence of delta virus infection on the virologic status in Egyptian patients with chronic hepatitis B virus genotype D.
Fouad R; Abdo M; Eldeen HG; Sabry D; Atef M; Ahmed R; Zayed N
J Med Virol; 2016 May; 88(5):837-42. PubMed ID: 26488214
[TBL] [Abstract][Full Text] [Related]
12. Transmission of hepatitis B and hepatitis delta viruses in the households of chronic hepatitis B surface antigen carriers: a regression analysis of indicators of risk.
Craxì A; Tinè F; Vinci M; Almasio P; Cammà C; Garofalo G; Pagliaro L
Am J Epidemiol; 1991 Sep; 134(6):641-50. PubMed ID: 1951268
[TBL] [Abstract][Full Text] [Related]
13. The medical impact of hepatitis D virus infection in Uzbekistan.
Khodjaeva M; Ibadullaeva N; Khikmatullaeva A; Joldasova E; Ismoilov U; Colombo M; Caviglia GP; Rizzetto M; Musabaev E
Liver Int; 2019 Nov; 39(11):2077-2081. PubMed ID: 31505080
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis delta genotype 5 is associated with favourable disease outcome and better response to treatment compared to genotype 1.
Spaan M; Carey I; Bruce M; Shang D; Horner M; Dusheiko G; Agarwal K
J Hepatol; 2020 Jun; 72(6):1097-1104. PubMed ID: 31981726
[TBL] [Abstract][Full Text] [Related]
15. Migratory flow and hepatitis delta infection in Italy: A new challenge at the beginning of the third millennium.
Stroffolini T; Ciancio A; Furlan C; Vinci M; Fontana R; Russello M; Colloredo G; Morisco F; Coppola N; Babudieri S; Ferrigno L; Sagnelli C; Sagnelli E
J Viral Hepat; 2020 Sep; 27(9):941-947. PubMed ID: 32338810
[TBL] [Abstract][Full Text] [Related]
16. Anti-hepatitis delta virus seroprevalence and risk factors in patients with hepatitis B in Southeast Turkey.
Celen MK; Ayaz C; Hosoglu S; Geyik MF; Ulug M
Saudi Med J; 2006 May; 27(5):617-20. PubMed ID: 16680248
[TBL] [Abstract][Full Text] [Related]
17. Quantification of serum markers of hepatitis B (HBV) and Delta virus (HDV) infections in patients with chronic HDV infection.
Ricco G; Popa DC; Cavallone D; Iacob S; Salvati A; Tabacelia D; Oliveri F; Mascolo G; Bonino F; Yuan Q; Xia NS; Gheorghe L; Brunetto MR
J Viral Hepat; 2018 Aug; 25(8):911-919. PubMed ID: 29577518
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B and Delta virus are prevalent but often subclinical co-infections among HIV infected patients in Guinea-Bissau, West Africa: a cross-sectional study.
Hønge BL; Jespersen S; Medina C; Té Dda S; da Silva ZJ; Lewin S; Østergaard L; Erikstrup C; Wejse C; Laursen AL; Krarup H;
PLoS One; 2014; 9(6):e99971. PubMed ID: 24915064
[TBL] [Abstract][Full Text] [Related]
19. Virological and clinical characteristics of hepatitis delta virus in South Asia.
Mumtaz K; Ahmed US; Memon S; Khawaja A; Usmani MT; Moatter T; Hamid S; Jafri W
Virol J; 2011 Jun; 8():312. PubMed ID: 21689416
[TBL] [Abstract][Full Text] [Related]
20. High rates of cirrhosis and severe clinical events in patients with HBV/HDV co-infection: longitudinal analysis of a German cohort.
Bockmann JH; Grube M; Hamed V; von Felden J; Landahl J; Wehmeyer M; Giersch K; Hall MT; Murray JM; Dandri M; Lüth S; Lohse AW; Lütgehetmann M; Schulze Zur Wiesch J
BMC Gastroenterol; 2020 Jan; 20(1):24. PubMed ID: 32000689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
